125 related articles for article (PubMed ID: 3101286)
1. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
de Wit HJ; Scheer G; Muradin J; van der Does JA
Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
[TBL] [Abstract][Full Text] [Related]
2. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
3. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
Wensley RT; Snape TJ
Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
[TBL] [Abstract][Full Text] [Related]
4. A simple plasma anticoagulant-exchange method to increase the recovery of factor VIII in therapeutic concentrates.
Cumming AM; Wensley RT; Winkelman L; Lane RS
Vox Sang; 1990; 58(4):264-9. PubMed ID: 2119086
[TBL] [Abstract][Full Text] [Related]
5. Improved yields of factor VIII from heparinized plasma.
Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
[TBL] [Abstract][Full Text] [Related]
6. Preparation of cryoprecipitated factor VIII concentrates.
Slichter SJ; Counts RB; Henderson R; Harker LA
Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
[TBL] [Abstract][Full Text] [Related]
7. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
Vermeer C; Soute BA; Ates G; Brummelhuis HG
Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
[TBL] [Abstract][Full Text] [Related]
8. Influence of the primary anticoagulant on the recovery of factor VIII.
Rock G
Vox Sang; 1988; 54(2):125-6. PubMed ID: 3131962
[No Abstract] [Full Text] [Related]
9. The influence of anticoagulant on the in vitro level and stability of factor VIII procoagulant activity.
Cumming AM; Wensley RT; Power DM; Delamore IW
Thromb Res; 1987 Apr; 46(2):391-5. PubMed ID: 3111005
[No Abstract] [Full Text] [Related]
10. The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.
DePalma L; Criss VR; Luban NL
Transfusion; 1993 Sep; 33(9):717-20. PubMed ID: 8212116
[TBL] [Abstract][Full Text] [Related]
11. Effect of citrate anticoagulants on factor VIII levels in plasma.
Rock G; Tittley P; Fuller V
Transfusion; 1988; 28(3):248-52. PubMed ID: 3130694
[TBL] [Abstract][Full Text] [Related]
12. Accumulative effect of DDAVP and heparin in increasing plasma factor VIII levels.
Rock G; Palmer DS
Vox Sang; 1981; 41(1):56-60. PubMed ID: 6798759
[TBL] [Abstract][Full Text] [Related]
13. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
Prowse C; Waterston YG; Dawes J; Farrugia A
Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
[TBL] [Abstract][Full Text] [Related]
14. Clotting factor activity in cryoprecipitates and supernatant plasma prepared from blood collected into ACD, ACD-adenine, CPD, and CPD-adenine and from plasma collected by plasmapheresis.
Graybeal FQ; Mooreside DE; Langdell RD
Transfusion; 1969; 9(3):135-40. PubMed ID: 5782206
[No Abstract] [Full Text] [Related]
15. Contributions to the optimal use of human blood. VIII. Stability of blood coagulation factor VII during collection and storage of whole blood and plasma.
Vermeer C; Soute BA; Ates G; Hellings JA; Brummelhuis HG
Vox Sang; 1976; 31(1 SUPPL):55-67. PubMed ID: 12616
[TBL] [Abstract][Full Text] [Related]
16. Characterization of factors affecting the stability of frozen heparinized plasma.
Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
[TBL] [Abstract][Full Text] [Related]
17. Proceedings: Improved factor VIII yield in cryoprecipitate using a quick thaw technique.
Davidson JF; McAdam JH; Mackenzie MJ; Kavanagh ML
Thromb Diath Haemorrh; 1975 Nov; 34(2):590. PubMed ID: 1198502
[No Abstract] [Full Text] [Related]
18. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
Morgenthaler JJ; Zuber T; Friedli H
Vox Sang; 1985; 48(1):8-17. PubMed ID: 3918394
[TBL] [Abstract][Full Text] [Related]
19. [Influence of citrate-phosphate-glucose solutions on the stability of antihemophilic globulin (AHG) in the blood and on the preparation of frozen AHG precipitates].
Vlcková M; Zoubková M
Vnitr Lek; 1970 Aug; 16(8):733-8. PubMed ID: 5456663
[No Abstract] [Full Text] [Related]
20. A clinical trial of red-cell concentrate prepared from blood collected in half-strength citrate anticoagulant.
Murphy WG; Palmer JB; Wilson R; Prowse CV; McClelland DB
Transfus Med; 1991 Mar; 1(1):25-9. PubMed ID: 9259823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
